RMI Partners

About RMI Partners

RMI Partners is a venture capital firm founded in 2012, focused on providing funding and strategic support to innovative companies within the life sciences sector. They specialize in high-impact therapeutic solutions, advanced technologies, pharmaceutical developments, and biotechnology advancements. RMI Partners brings to bear a strategic approach, targeting companies at various stages of the business lifecycle, from early-stage startups to mature enterprises seeking expansion or transition opportunities. Their investment thesis revolves around identifying and capitalizing on breakthrough scientific endeavors that have the potential to transform patient care and significantly improve medical outcomes. In line with this, they actively seek out entrepreneurial teams who have developed, or are in the process of developing, novel products or services that address unmet medical needs or have the capacity to redefine existing treatment paradigms within the BioTech, FinTech (including Financial Services), and HealthTech (inclusive of Fitness) industries. The firm's approach is underpinned by a deep understanding of the complex regulatory landscape and market dynamics specific to the healthcare and biotechnology sectors, with an emphasis on the critical importance of intellectual property rights and competitive advantage. RMI Partners operates primarily out of Moscow, Russia, leveraging a network of industry experts, researchers, and business professionals to guide their portfolio companies towards commercialization success. They take on a mentorship role, providing not just financial support, but also strategic guidance and operational expertise to ensure their investees are positioned for growth and market leadership. This comprehensive support system is designed to maximize return on investment while fostering groundbreaking advancements in science and technology.